Rural-urban differences in breast and colorectal cancer screening among US women, 2014-2019

Introduction: Prior research has revealed rural populations have lower rates of breast and colorectal cancer screening compared to their urban counterparts in the USA. An increasing number of rural hospitals have closed, with rural residents reporting skipping diagnosing imaging and preventative car...

Full description

Saved in:
Bibliographic Details
Published in:Rural and remote health 2022-09, Vol.22 (3), p.1-11
Main Authors: Theodoropoulos, Nicholas, Xie, Hui, Wang, Qian, Wen, Chi, Li, Yannan
Format: Article
Language:English
Subjects:
Breast
Breast Neoplasms - diagnosis
Breast Neoplasms - epidemiology
Cancer
Cancer in women
Colon (Anatomy)
Colorectal Neoplasms - diagnosis
Colorectal Neoplasms - epidemiology
Colorectal Neoplasms - prevention & control
Cross-Sectional Studies
Diagnosis
disparity
Early Detection of Cancer - methods
Evaluation
Female
Health aspects
Humans
Medical screening
Prevention
Rural Population
Rural women
screening
Social aspects
urban
USA
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction: Prior research has revealed rural populations have lower rates of breast and colorectal cancer screening compared to their urban counterparts in the USA. An increasing number of rural hospitals have closed, with rural residents reporting skipping diagnosing imaging and preventative care due to a lack of access. Considering increasing rural hospital closures, this study investigated disparities in breast and colorectal cancer screening between urban and rural women in the USA. Methods: This cross-sectional study analyzed the Behavioral Risk Factor Surveillance System (BRFSS) data 2014-2019. Focusing on women aged 50-74 years, this study evaluated the prevalence of breast cancer and colorectal cancer (CRC) screening overall and by urban-rural location using multivariable logistic regressions. Results: During the study period, the adjusted prevalences of breast cancer screening were 80.0% and 77.1% (p
ISSN:1445-6354
1445-6354
DOI:10.22605/RRH7339